SLP Simulations Plus Inc. Return on Sales by Gross Profit

SLP (Simulations Plus Inc.) - company brandmark

Simulations Plus, Inc. (SLP) reduces costs for pharmaceutical companies through digital test simulation, yet long-term success depends on the integration of its software into the R&D processes of industry behemoths. The gross margin percentage visualizes this balance, where the parameter value reaches 62.40. Current growth confirms the expansion strategy within the AI subscription segment and the strengthening of its monopoly position in the biosimulation market.

SLP (Simulations Plus Inc.) Gross Profitability history from 07/04/2022 to 10/18/2026

Comprehensive metric breakdowns and analytics for Simulations Plus Inc. (SLP)

Basic company analysis:SLP - Simulations Plus Corp
Finished products of Simulations Plus Corp

The monopoly status of Simulations Plus (SLP) in biosimulation for drug discovery allows for the tracking of cloud SaaS monetization efficiency through the company's gross margin. This indicator is calculated as revenue minus direct production costs, where consistently high values confirm low software scaling costs and high added value of the product within the R&D cycles of pharma behemoths.

Key competitors

VEEV - Return on Sales by Gross Profit|DOCS (Doximity Network) - Gross Margin|HQY (HealthEquity, Inc.) - Gross Profit Ratio|Gross Margin WAY|CRVL: Gross Profitability Margin|Privia Health Group - Return on Gross Profit|Huron Consulting - Gross Profitability|Certara Software - Gross Margin|Return on Sales by Gross Profit Omnicell Health OMCL|GDRX: Gross Margin|Gross Return on Sales SDGR|Gross Profitability Phreesia|Gross Return on Sales OMDA (Omada Health)|Gross Profitability Evolent Health, Inc. (EVH)|Return on Gross Profit HealthStream, Inc. HSTM|Gross Margin DH (Definitive Corp)|Return on Sales by Gross Profit consensus.com (CCSI)|AGL: Return on Gross Profit|Return on Sales by Gross Profit Absci Corporation ABSI|SY: Gross Margin|Return on Gross Profit NRC Health|Gross Profitability Spok Corp|optimizerx.com (OPRX) - Return on Sales by Gross Profit|Return on Gross Profit TBRG (TruBridge)|SOPH: Gross Profitability Margin|Gross Margin HCAT (Health Catalyst Inc)|CCLD - Return on Gross Profit|researchsolutions.com - Gross Margin|Return on Sales by Gross Profit DLH Corp DLHC|OneMedNet Corp. (ONMD) - Gross Profitability|Return on Gross Profit Scienture Holdings|Return on Gross Profit HCTI|ispecimen.com (ISPC) - Return on Sales by Gross Profit|Return on Gross Profit BFRG (Bullfrog AI Holdings)|WORX - Gross Profit Margin|Gross Profitability MSP Recovery Inc. MSPR|ICCT: Gross Return on Sales|TRxADE HEALTH, Inc. - Gross Margin|Gross Profit Margin Orgenesis Corporation|RCM (R1 RCM Inc.) - Return on Gross Profit|Gross Profit Margin Sharecare, Inc. (SHCR)|Gross Profitability Streamline Health|SYRA: Gross Profit Rate|Gross Profitability Apollo Medical Holdings Inc. (AMEH)|Return on Sales by Gross Profit Model N Corporation|NextGen - Return on Gross Profit